Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
2011
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
The Alzheimer's disease–protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool
2017
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
Siglec-mediated regulation of immune cell function in disease
2014
Siglec functions of microglia
2014
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
2021 StandoutNobel
Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins
2014
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
2013
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
The past and future of CD33 as therapeutic target in acute myeloid leukemia
2014
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain–Barré syndrome and Miller Fisher syndrome
2012
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Systemic sclerosis
2017 Standout
CD33 in Alzheimer's Disease
2013
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Cancer stem cells revisited
2017 Standout
Immunoreceptor tyrosine‐based inhibition motifs: a quest in the past and future
2008
Biological roles of glycans
2016 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
2009 Standout
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Neutrophils, from Marrow to Microbes
2010 Standout
The AID Dilemma
2012 StandoutNobel
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
2018
Basic and Clinical Immunology of Siglecs
2008
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism
2019
Clinical and experimental research in antituberculosis drug-induced hepatotoxicity: a review
2017
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
2022 StandoutNobel
Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway
2021 StandoutNobel
Siglecs as Immune Cell Checkpoints in Disease
2020
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
2021 StandoutNobel
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Siglecs as targets for therapy in immune-cell-mediated disease
2009
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2008 Standout
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Peter Häusermann being referenced
Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis
2008
Cutaneous Plasmablastic Lymphoma in an HIV-Positive Male: An Unrecognized Cutaneous Manifestation
2004
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
2015
Homozygosity for the c.917A → T (p.N306l) Polymorphism in the EVER2/TMC8 Gene of Two Sisters with Epidermodysplasia Verruciformis Lewandowsky-Lutz Originally Described by Wilhelm Lutz
2010
Phosphorylated ITIMs Enable Ubiquitylation of an Inhibitory Cell Surface Receptor
2007
Immediate Hypersensitivity to Rifampicin in 3 Patients: Diagnostic Procedures and Induction of Clinical Tolerance
2006
ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2
2007